Financial Results

Show all

2026

Q1 2026

Quarter Ended Mar 31, 2026

2025

FY 2025

Fiscal Year Ended Dec 31, 2025

Q3 2025

Quarter Ended Sep 30, 2025

Q2 2025

Quarter Ended Jun 30, 2025

Q1 2025

Quarter Ended Mar 31, 2025

2024

FY 2024

Fiscal Year Ended Dec 31, 2024

Q3 2024

Quarter Ended Sep 30, 2024

Q2 2024

Quarter Ended Jun 30, 2024

Q1 2024

Quarter Ended Mar 31, 2024

2023

FY 2023

Fiscal Year Ended Dec 31, 2023

Q3 2023

Quarter Ended Sep 30, 2023

Q2 2023

Quarter Ended Jun 30, 2023

Q1 2023

Quarter Ended Mar 31, 2023

2022

FY 2022

Fiscal Year Ended Dec 31, 2022

Q3 2022

Quarter Ended Sep 30, 2022

Q2 2022

Quarter Ended Jun 30, 2022

Q1 2022

Quarter Ended Mar 31, 2022

2021

FY 2021

Fiscal Year Ended Dec 31, 2021

Q3 2021

Quarter Ended Sep 30, 2021

Q2 2021

Quarter Ended Jun 30, 2021

Q1 2021

Quarter Ended Mar 31, 2021

2020

FY 2020

Fiscal Year Ended Dec 31, 2020

Q3 2020

Quarter Ended Sep 30, 2020

Q2 2020

Quarter Ended Jun 30, 2020

Q1 2020

Quarter Ended Mar 31, 2020

2019

FY 2019

Fiscal Year Ended Dec 31, 2019

Q3 2019

Quarter Ended Sep 30, 2019

Q2 2019

Quarter Ended Jun 30, 2019

Q1 2019

Quarter Ended Mar 31, 2019

2018

FY 2018

Fiscal Year Ended Dec 31, 2018

Q3 2018

Quarter Ended Sep 30, 2018

Q2 2018

Quarter Ended Jun 30, 2018

Q1 2018

Quarter Ended Mar 31, 2018

2017

FY 2017

Fiscal Year Ended Dec 31, 2017

Corporate Presentation

Click here to view our corporate presentation or on the image below
Corporate Presentation
IP Portfolio
View Our Pipeline
Contact NRx Pharmaceuticals